prnewswire.com
May 16, 2008
Frank Greenway, M.D. Joins Catalyst's Scientific Advisory Board Andrew Forman Retained As Business Development & Investor Relations Consultant CORAL GABLES, Fla., May 16 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today reported financial results for the...
[read full story]